Are Breast Cancer Treatments Improving?

Marlene Kurban • October 10, 2022

A recent article in Yale Medicine notes that some breast cancer patients are getting less chemotherapy, or bypassing it entirely. Treatments are changing, and clinical trial results are showing that women with certain breast cancers may not need aggressive chemotherapy with its often debilitating, long-term side effects.

Chemotherapy, which is used to kill cancer cells, shrink tumors, and help make other treatments more effective, commonly causes fatigue, hair loss, nausea, and sometimes affects heart function. Long-term complications, though less common, include neuropathy, leukemia, and heart problems. Breast cancer patients who have good outcomes with less intensive medical treatments are likely to experience less anxiety and a higher quality of life.

The article notes that two types of breast cancer respond well to less aggressive chemo or even none at all: HR-positive, which is the largest breast cancer subtype, and HER2-positive, which was once a fatal disease in the past but is effectively treated now with limited chemotherapy. Specialized testing and genomic profiling tests can help doctors determine which patients will benefit from chemotherapy and which cancers are more likely to return. Depending on the type of breast cancer, targeted therapies and anti-estrogen therapies can also lower the risk of recurrence.

May 29, 2025
InterCommunity First to Offer Inpatient Cocaine Withdrawal Management in  Greater Hartford
May 27, 2025
Big Improvements Happening at InterCommunity! 
May 21, 2025
Health, Hope & Healing, One Step at a Time Reflecting on Mental Health Awareness Month at InterCommunity
April 25, 2025
Breathe Easier This Spring: Managing Allergies with InterCommunity
April 24, 2025
InterCommunity’s Journey Forward
March 4, 2025
InterCommunity Celebrates Successful Ribbon-Cutting for Expanded Health Facility
February 26, 2025
Changing the Meaning of Care
February 13, 2025
CT Community Health Centers Navigating Uncertainty, Funding Delays
January 17, 2025
InterCommunity will continue to inspire hope and promote whole-person health by providing high-quality, affordable, compassionate healthcare for everyone.
LDBI Staff
January 6, 2025
For individuals battling opioid addiction, especially those impacted by fentanyl, hope can feel out of reach. InterCommunity Inc. is changing that. As the only provider in the region offering Low-Dose Buprenorphine Induction (LDBI), InterCommunity is leading the way with a safe, more compassionate approach to recovery.
More Posts